Lipa Meir & Co. is Israel’s leading law firm in the field of Health & Life Sciences law.
In a nutshell, our health law practice encompasses not only the law of health care provision and financing, which is traditionally deemed the core engagement of this practice area, but other and diverse areas that focus on the interlinking of law and health, including: research; ethical questions; the right of patients to privacy; pharmaceutical and device manufacturers, occupational health and safety regulations, medical malpractice, relevant rules and regulations and healthcare mergers and acquisitions. Thus, we pride ourselves in having an in depth understanding of the field’s multifaceted nature.Our firm represents, among others, Clalit Health Services, the largest Health Maintenance Organization (HMO) in the country, as well as Clalit’s many subsidiaries, including Mor – the Institute for Medical Information Ltd., S.L.H. Health Services Ltd., Clalit Medical Engineering Ltd., Tel-Bar Industries for Health Institutions Ltd., Mor-Mar Diagnostic Imaging Ltd., and Mor Research Applications Ltd., the Clalit Group’s technology transfer company.
Clalit is one of the world’s largest HMO’s, providing health services to more than four million insured members through some 36,000 employees, operating 14 hospitals and approximately 1,300 clinics nationwide.
Advice given to the Calit Group includes civil and commercial law in general, as well as the fields integral and specific to Clalit’s operations as an HMO in particular. Such advice encompasses a multitude of disciplines, such as “traditional” corporate advice; administrative and regulatory issues; drafting legislative instruments; insurance law; litigation; research (in particular big data research), tenders; `and more.
As part of the advice to Clalit, our firm provides legal advice in relation to the complementary service programs that Clalit offers its members (named the “Gold” and “Platinum” programs), including drafting agreements and advising on engagements with various service providers (including private hospitals, physicians, and medical and paramedical service providers); representation in legal proceedings; representation vis-à-vis regulators; and drafting of health insurance policies. In addition, in this context, the firm has developed special expertise in group health insurance in general and in collective long-term care insurance in particular, and handles all aspects of the collective long-term care insurance for members of Clalit, covering more than 1.8 million insured members.
Our firm represents a variety of other clients in the health field, including suppliers and clients in the world of pharmaceutical and medical devices and biotechnology. Such advice extends to the drafting of clinical and other trial agreements, R&D agreements, agreements for collaborations with medical institutions, universities and research entities, manufacturing agreements, distribution agreements, exploitation of intellectual property, and more.
The Healthcare and life sciences Department was ranked in tier 1 in The Legal 500: “Lipa Meir & Co provides comprehensive commercial and regulatory advice to healthcare providers, medical device manufacturers and distributors, private medical centres and tech companies… Gary Copelovitz is instructed by health services giant Clalit Health Services.”
News & Publications
FutureMed 2020 – Online Conference
The first wave of the CoronaVirus pandemic has hit every sphere of public and private life. Different governments have presented different approaches, all of which have been asked to plan and adopt health management and new regulations on the move, while no one has an unequivocal answer to the key question: What is the right […]
The Legal 500 Europe, Middle East & Africa 2020 rankings released
Lipa Meir & Co has been recommended as a TOP-TIER FIRM in 3 practice areas: – Energy – Healthcare and life sciences – Restructuring and insolvency Lipa Meir & Co has also been recommended in the following 13 practice areas: – Banking and finance – Capital markets – Commercial, corporate and M&A – Competition antitrust […]
Israeli Medical Cannabis Export
Yesterday, the Israeli cabinet approved the long-awaited export of medical cannabis from Israel. The Israeli cabinet decided to permit export of medical cannabis products to countries that accepted the Single Convention on Narcotic Drugs of 1961 and willing to import medical cannabis from Israel. Export of medical cannabis products will be permitted, but no plants, […]